Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine

• Status: Completed
• Trial end date: 2011-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients receiving perioperative intravenous lidocaine, post operative restoration of bowel movement will be faster and decrease pain intensity, opioid consumption and side effects, length of hospital stay; probably as a result of a significant opioid sparing and attenuated inflammatory response.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGill University Health Center; McGill University Health Centre/Research Institute of the McGill University Health Centre
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• scheduled to undergo laparoscopic colorectal resection

Exclusion Criteria:

• patients who have trouble to understand, read or communicate either in French or in English

• dementia

• patients suffering from severe physical disability (arthritis, neuromuscular dysfunction, stroke, paraplegia) or inability to walk or conduct daily activity

• patients suffering from severe cardiac or respiratory disease (status ASA IV

• patients suffering from metastatic carcinoma

• patients who have a history of chemoradiation within the six months preceding surgery

• allergy to lidocaine

• morbid obesity

• patients with chronic opioid use.